[Study on high-efficiency gene transfer of pseudotyped HIV vector]. 2001

C S Liu, and L Song, and B H Kong, and D X Ma, and M Wei
Bioengineering Center, Qilu Hospital of Shandong University, Jinan 250012, China. chunsheng_l@yahoo.com

OBJECTIVE To investigate the high-efficiency of pseudotyped HIV as gene transfer vector. METHODS Three plasmids of pseudotyped HIV gene transfer vector system were transferred into packaging cell line 293T by Ca3 (PO4)2 precipitation method. GFP (Green Fluorescence Protein) or HSV-tk gene was constructed in the plasmid pHR'CS respectively (pHR'CS.GFP or pHR'CS.HSV-tk). The pseudotyped HIV particles were observed through electronic microscopy and were measured through spectrofluorophotometer. High titer pseudotyped HIV was harvested from volume of virus-producing cell supernatant and concentrated. Ovarian epithelial cancer cell line SKOV3 and normal human gingival fibroblast cell GF were infected by pseudotyped HIV. PCR and RT-PCR were resorted to demonstrate the successful transduction and transcription of the HSV-tk gene. After administration of GCV, the changes of those cells and apoptosis were observed through optical microscopy. The cytotoxicity efficacy of HSV-tk/GCV system was evaluated by MTT method. The growth inhibition rate (GIR) of cells and inhibition concentration 50 (IC50) were counted. RESULTS The above plasmids were effectively transferred into 293T cell. A lot of pseudotyped HIV particles were observed through electronic microscopy. The virus supernatant had a high absorbing value at 510 nm through spectrofluorophotometer, which proved the existence of virus. After pseudotyped HIV infection, SKOV3 and GF had remarkable infection rate. 600 bp strand was seen through PCR and RT-PCR. Changes and apoptosis of cells followed by administration of GCV were observed. The MTT method showed that the cytotoxicity efficacy of GCV was high to SKOV3 and GF cell. CONCLUSIONS The pseudotyped HIV is a high-efficiency gene transfer vector.

UI MeSH Term Description Entries
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005822 Genetic Vectors DNA molecules capable of autonomous replication within a host cell and into which other DNA sequences can be inserted and thus amplified. Many are derived from PLASMIDS; BACTERIOPHAGES; or VIRUSES. They are used for transporting foreign genes into recipient cells. Genetic vectors possess a functional replicator site and contain GENETIC MARKERS to facilitate their selective recognition. Cloning Vectors,Shuttle Vectors,Vectors, Genetic,Cloning Vector,Genetic Vector,Shuttle Vector,Vector, Cloning,Vector, Genetic,Vector, Shuttle,Vectors, Cloning,Vectors, Shuttle
D006678 HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. AIDS Virus,HTLV-III,Human Immunodeficiency Viruses,Human T-Cell Lymphotropic Virus Type III,Human T-Lymphotropic Virus Type III,LAV-HTLV-III,Lymphadenopathy-Associated Virus,Acquired Immune Deficiency Syndrome Virus,Acquired Immunodeficiency Syndrome Virus,Human Immunodeficiency Virus,Human T Cell Lymphotropic Virus Type III,Human T Lymphotropic Virus Type III,Human T-Cell Leukemia Virus Type III,Immunodeficiency Virus, Human,Immunodeficiency Viruses, Human,Virus, Human Immunodeficiency,Viruses, Human Immunodeficiency,AIDS Viruses,Human T Cell Leukemia Virus Type III,Lymphadenopathy Associated Virus,Lymphadenopathy-Associated Viruses,Virus, AIDS,Virus, Lymphadenopathy-Associated,Viruses, AIDS,Viruses, Lymphadenopathy-Associated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014162 Transfection The uptake of naked or purified DNA by CELLS, usually meaning the process as it occurs in eukaryotic cells. It is analogous to bacterial transformation (TRANSFORMATION, BACTERIAL) and both are routinely employed in GENE TRANSFER TECHNIQUES. Transfections
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D041722 Genes, Transgenic, Suicide Genes that are used transgenically, i.e., via GENE TRANSFER TECHNIQUES to induce CELL DEATH. Genes, Suicide, Metabolic, Transgenic,Genes, Transgenic Apoptosis-Inducing,Suicide Genes, Transgenic,Transgenic Metabolic Suicide Genes,Transgenic Suicide Genes,Apoptosis-Inducing Transgenes,Suicide Genes, Transduced,Suicide Transgenes,Transduced Suicide Genes,Apoptosis Inducing Transgenes,Apoptosis-Inducing Gene, Transgenic,Apoptosis-Inducing Genes, Transgenic,Apoptosis-Inducing Transgene,Gene, Transduced Suicide,Gene, Transgenic Apoptosis-Inducing,Gene, Transgenic Suicide,Genes, Transduced Suicide,Genes, Transgenic Apoptosis Inducing,Genes, Transgenic Suicide,Suicide Gene, Transduced,Suicide Gene, Transgenic,Suicide Transgene,Transduced Suicide Gene,Transgene, Apoptosis-Inducing,Transgene, Suicide,Transgenes, Apoptosis-Inducing,Transgenes, Suicide,Transgenic Apoptosis-Inducing Gene,Transgenic Apoptosis-Inducing Genes,Transgenic Suicide Gene

Related Publications

C S Liu, and L Song, and B H Kong, and D X Ma, and M Wei
February 2001, Hunan yi ke da xue xue bao = Hunan yike daxue xuebao = Bulletin of Hunan Medical University,
C S Liu, and L Song, and B H Kong, and D X Ma, and M Wei
November 1999, Gene therapy,
C S Liu, and L Song, and B H Kong, and D X Ma, and M Wei
January 2013, The journal of gene medicine,
C S Liu, and L Song, and B H Kong, and D X Ma, and M Wei
January 1998, Advances in experimental medicine and biology,
C S Liu, and L Song, and B H Kong, and D X Ma, and M Wei
April 2000, Gene therapy,
C S Liu, and L Song, and B H Kong, and D X Ma, and M Wei
February 2001, Gene therapy,
C S Liu, and L Song, and B H Kong, and D X Ma, and M Wei
June 2000, Gene therapy,
C S Liu, and L Song, and B H Kong, and D X Ma, and M Wei
February 2012, Gene therapy,
C S Liu, and L Song, and B H Kong, and D X Ma, and M Wei
April 2007, Gene therapy,
Copied contents to your clipboard!